Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment

By Rhalem A.   Sahibi H.   Lasri S.   Jaffe C.L.  

Veterinary Immunology and Immunopathology, Vol. 71, Iss. 1, 1999-10 ,pp. : 69-76

Elsevier

Access to resources Recommend Favorite

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis

By Quinnell R.J.   Courtenay O.   Garcez L.M.   Kaye P.M.   Shaw M.A.   Dye C.   Day M.J.  

Veterinary Immunology and Immunopathology, Vol. 91, Iss. 3, 2003-02 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy

By Moreno J.   Nieto J.   Chamizo C.   Gonzalez F.   Blanco F.   Barker D.C.   Alvar J.  

Veterinary Immunology and Immunopathology, Vol. 71, Iss. 3, 1999-11 ,pp. : 181-195

Elsevier

Access to resources Recommend Favorite

Evaluation of serum cystatin-C in dogs with visceral leishmaniasis

By Pasa S.  

Veterinary Research Communications, Vol. 33, Iss. 6, 2009-08 ,pp. : 529-534

Springer Publishing Company

Access to resources Recommend Favorite

Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis

By Vexenat J.A.   Croft S.L.   Furtado Campos J.H.   Miles M.A.  

Veterinary Parasitology, Vol. 77, Iss. 1, 1998-05 ,pp. : 71-73

Elsevier

Access to resources Recommend Favorite